Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Schering-Plough
Progeria Research Foundation
Information provided by:
Boston Children’s Hospital
ClinicalTrials.gov Identifier:
NCT00425607
First received: January 22, 2007
Last updated: December 24, 2007
Last verified: December 2007